DEFA14A: Others
Apr 25 16:41 ET
DEF 14A: Definitive information statements
Apr 25 16:38 ET
Revolution Medicines | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Mar 4 17:27 ET
Revolution Medicines | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 26 17:07 ET
Revolution Medicines | 8-K: Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress
Feb 26 16:09 ET
Revolution Medicines | 8-K: Current report
Jan 9 00:00 ET
Revolution Medicines | 8-K/A: Current report (Amendment)
Dec 26, 2023 00:00 ET
Revolution Medicines | 8-K: Current report
Nov 9, 2023 09:20 ET
Revolution Medicines | 8-K: Revolution Medicines Reports Third Quarter 2023 Financial Results and Update on Corporate Progress
Nov 6, 2023 16:05 ET
Revolution Medicines | DEFA14A: Others
Nov 1, 2023 07:15 ET
Revolution Medicines | 8-K: Current report
Nov 1, 2023 07:08 ET
Revolution Medicines | 8-K: Current report
Oct 23, 2023 06:11 ET
Revolution Medicines | 8-K: Current report
Oct 13, 2023 11:54 ET
Revolution Medicines | DEFM14A: Definitive proxy statement relating to merger or acquisition
Sep 29, 2023 16:19 ET
Revolution Medicines | 8-K: Current report
Sep 5, 2023 16:02 ET
Revolution Medicines | 8-K: Revolution Medicines Reports Second Quarter 2023 Financial Results and Update on Corporate Progress
Aug 8, 2023 16:04 ET
Revolution Medicines | 8-K: Current report
Aug 1, 2023 07:10 ET
Revolution Medicines | 8-K: Current report
Jun 9, 2023 16:07 ET
Revolution Medicines | 8-K: Revolution Medicines Reports First Quarter 2023 Financial Results and Update on Corporate Progress
May 8, 2023 16:04 ET
Revolution Medicines | DEFA14A: Others
Apr 26, 2023 16:36 ET
No Data
No Data